Home » Stocks » SRSA

Sarissa Capital Acquisition Corp. (SRSA)

Sarissa Capital Acquisition currently trades with the ticker symbol SRSAU
Stock Price: $10.11 USD -0.09 (-0.88%)
Updated Oct 28, 2020 12:57 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 221.16M
Revenue (ttm) n/a
Net Income (ttm) -3,793
Shares Out 21.88M
EPS (ttm) 0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 28, 2020
Last Price $10.11
Previous Close $10.20
Change ($) -0.09
Change (%) -0.88%
Day's Open 10.15
Day's Range 10.10 - 10.34
Day's Volume 37,891
52-Week Range 0.00 - 10.34

More Stats

Market Cap 221.16M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 21.88M
Float n/a
EPS (basic) n/a
EPS (diluted) 0.00
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income n/a
Net Income -3,793
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name Sarissa Capital Acquisition Corp.
Country United States
CEO Alexander Denner

Stock Information

Ticker Symbol SRSA
Stock Exchange NASDAQ
Industry Blank Checks / SPAC
Unique Identifier NASDAQ: SRSA
IPO Date October 21, 2020

Description

Sarissa Capital Acquisition Corp. is a newly incorporated blank check company incorporated on August 12, 2020 as a Cayman Islands exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare and biopharma industry. We may pursue a transaction in which our shareholders immediately prior to the completion of our initial business combination would collectively own a minority interest in the post-business combination company. Our officers and directors have extensive experience in identifying, negotiating with and conducting due diligence on companies targeted for acquisition and consummating acquisitions of healthcare and biopharma companies.